{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:46:58Z","timestamp":1786985218951,"version":"build-2736575974"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32400969"],"award-info":[{"award-number":["32400969"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004608","name":"Jiangsu Province Natural Science Foundation","doi-asserted-by":"publisher","award":["BK20230636"],"award-info":[{"award-number":["BK20230636"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.bioorg.2025.108307","type":"journal-article","created":{"date-parts":[[2025,2,23]],"date-time":"2025-02-23T10:08:07Z","timestamp":1740305287000},"page":"108307","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Design, synthesis and antitumor activity evaluation of novel modified 18\u03b2-glycyrrhetinate derivatives as PPAR\u03b3 agonists"],"prefix":"10.1016","volume":"157","author":[{"given":"Hongyan","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuaijun","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinye","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingqing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiazi","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongxuan","family":"Ai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuheng","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liqun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingyu","family":"Ruan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhao","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2025.108307_bb0005","first-page":"623","article-title":"Synthesis and biological activity of glycyrrhetinic acid derivatives as antitumor agents, European journal medicine","volume":"178","author":"Zhou","year":"2019","journal-title":"Chemistry"},{"issue":"3","key":"10.1016\/j.bioorg.2025.108307_bb0010","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/bph.16228","article-title":"Licorice metabolite 18\u03b2-glycyrrhetinic acid activates G protein-gated inwardly rectifying K+ channels","volume":"181","author":"Chen","year":"2024","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bioorg.2025.108307_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.104598","article-title":"Structurally modified glycyrrhetinic acid derivatives as anti-inflammatory agents","volume":"107","author":"Bian","year":"2021","journal-title":"Bioorg. Chem."},{"issue":"4","key":"10.1016\/j.bioorg.2025.108307_bb0020","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.apsb.2015.05.005","article-title":"The antiviral and antimicrobial activities of licorice, a widely-used Chinese herb","volume":"5","author":"Wang","year":"2015","journal-title":"Acta Pharm. Sin. B"},{"issue":"1","key":"10.1016\/j.bioorg.2025.108307_bb0025","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1055\/a-0662-0296","article-title":"Anti-inflammatory 18\u03b2-glycyrrhetinin acid derivatives produced by biocatalysis","volume":"85","author":"Fan","year":"2019","journal-title":"Planta Med."},{"issue":"5","key":"10.1016\/j.bioorg.2025.108307_bb0030","doi-asserted-by":"crossref","first-page":"641","DOI":"10.3390\/ph16050641","article-title":"A review of the antiviral activities of glycyrrhizic acid, glycyrrhetinic acid and glycyrrhetinic acid monoglucuronide","volume":"16","author":"Zuo","year":"2023","journal-title":"Pharmaceuticals (Basel)"},{"issue":"10","key":"10.1016\/j.bioorg.2025.108307_bb0035","doi-asserted-by":"crossref","first-page":"4403","DOI":"10.21873\/anticanres.16636","article-title":"Unlocking synergistic potential: enhancing regorafenib efficacy in hepatocellular carcinoma through combination therapy with 18\u03b2-glycyrrhetinic acid","volume":"43","author":"Yang","year":"2023","journal-title":"Anticancer Res."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108307_bb0040","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/s41401-020-0383-9","article-title":"Research progress on the protective effects of licorice-derived 18\u03b2-glycyrrhetinic acid against liver injury","volume":"42","author":"Wu","year":"2021","journal-title":"Acta Pharmacol. Sin."},{"issue":"4","key":"10.1016\/j.bioorg.2025.108307_bb0045","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1021\/acs.molpharmaceut.2c00842","article-title":"Dual-ligand-functionalized liposomes based on glycyrrhetinic acid and cRGD for hepatocellular carcinoma targeting and therapy","volume":"20","author":"Qiu","year":"2023","journal-title":"Mol. Pharm."},{"issue":"23","key":"10.1016\/j.bioorg.2025.108307_bb0050","doi-asserted-by":"crossref","first-page":"3622","DOI":"10.3748\/wjg.v29.i23.3622","article-title":"18\u03b2-glycyrrhetinic acid inhibits proliferation of gastric cancer cells through regulating the miR-345-5p\/TGM2 signaling pathway","volume":"29","author":"Li","year":"2023","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.bioorg.2025.108307_bb0055","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s11010-012-1412-x","article-title":"18-Glycyrrhetinic acid potentiates Hsp90 inhibition-induced apoptosis in human epithelial ovarian carcinoma cells via activation of death receptor and mitochondrial pathway","volume":"370","author":"Yang","year":"2012","journal-title":"Mol. Cell. Biochem."},{"issue":"19","key":"10.1016\/j.bioorg.2025.108307_bb0060","doi-asserted-by":"crossref","first-page":"15012","DOI":"10.3390\/ijms241915012","article-title":"Synthesis and antiviral and antitumor activities of novel 18\u03b2-glycyrrhetinic acid derivatives","volume":"24","author":"Pan","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.bioorg.2025.108307_bb0065","first-page":"1086","article-title":"Pharmacological features of 18\u03b2-glycyrrhetinic acid: a pentacyclic triterpenoid of therapeutic potential","volume":"12","author":"Shinu","year":"2023","journal-title":"Plants (Basel)"},{"issue":"2","key":"10.1016\/j.bioorg.2025.108307_bb0070","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1042\/cs1020203","article-title":"Effect of glycyrrhetinic acid on 11\u03b2-hydroxysteroid dehydrogenase activity in normotensive and hypertensive subjects","volume":"102","author":"Van Uum","year":"2002","journal-title":"Clin. Sci."},{"issue":"12","key":"10.1016\/j.bioorg.2025.108307_bb0075","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1080\/17460441.2021.1956901","article-title":"Glycyrrhetinic acid: a promising scaffold for the discovery of anticancer agents","volume":"16","author":"Hussain","year":"2021","journal-title":"Expert Opin. Drug Discov."},{"issue":"6","key":"10.1016\/j.bioorg.2025.108307_bb0080","doi-asserted-by":"crossref","first-page":"924","DOI":"10.3390\/molecules22060924","article-title":"An overview of structurally modified glycyrrhetinic acid derivatives as antitumor agents","volume":"22","author":"Xu","year":"2017","journal-title":"Molecules"},{"issue":"5","key":"10.1016\/j.bioorg.2025.108307_bb0085","doi-asserted-by":"crossref","first-page":"498","DOI":"10.2174\/0929867323666160112122256","article-title":"Glycyrrhetinic acid and its derivatives: anti-cancer and cancer chemopreventive properties, mechanisms of action and structure-cytotoxic activity relationship","volume":"23","author":"Roohbakhsh","year":"2016","journal-title":"Curr. Med. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108307_bb0090","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.dsx.2014.09.015","article-title":"PPAR gamma gene-a review","volume":"9","author":"Janani","year":"2015","journal-title":"Diabetes & Metabolic Syndrome: Clinic. Res. Rev."},{"key":"10.1016\/j.bioorg.2025.108307_bb0095","article-title":"PPAR gamma in metabolism, immunity, and cancer: unified and diverse mechanisms of action","volume":"12","author":"Hernandezquiles","year":"2021","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"1","key":"10.1016\/j.bioorg.2025.108307_bb0100","doi-asserted-by":"crossref","first-page":"16179","DOI":"10.1371\/journal.pone.0016179","article-title":"Specific thiazolidinediones inhibit ovarian cancer cell line proliferation and cause cell cycle arrest in a PPAR\u03b3 independent manner","volume":"6","author":"Alalem","year":"2011","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.bioorg.2025.108307_bb0105","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.bbrc.2015.04.023","article-title":"PPAR\u03b3 inhibits ovarian cancer cells proliferation through upregulation of miR-125b","volume":"462","author":"Luo","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"6","key":"10.1016\/j.bioorg.2025.108307_bb0110","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1136\/jitc-2021-002548","article-title":"S100A4 enhances protumor macrophage polarization by control of PPAR-\u03b3-dependent induction of fatty acid oxidation","volume":"9","author":"Liu","year":"2021","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.bioorg.2025.108307_bb0115","article-title":"Macrophage M1\/M2 polarization","volume":"877","author":"Chen","year":"2020","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bioorg.2025.108307_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2023.175749","article-title":"PPAR\u03b3 agonist pioglitazone enhances colorectal cancer immunotherapy by inducing PD-L1 autophagic degradation","volume":"950","author":"Jia","year":"2023","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bioorg.2025.108307_bb0125","first-page":"6127","article-title":"PPAR\u03b3 activation serves as therapeutic strategy against bladder cancer via inhibiting PI3K-Akt signaling pathway","volume":"204","author":"Lv","year":"2019","journal-title":"BMC Cancer"},{"issue":"3","key":"10.1016\/j.bioorg.2025.108307_bb0130","doi-asserted-by":"crossref","first-page":"197","DOI":"10.2174\/1568009619666191209102015","article-title":"PPAR\u03b3 agonists in combination cancer therapies","volume":"20","author":"Mrowka","year":"2020","journal-title":"Current Cancer Drug Target"},{"issue":"5","key":"10.1016\/j.bioorg.2025.108307_bb0135","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1158\/1535-7163.MCT-07-0022","article-title":"Structure-dependent activity of glycyrrhetinic acid derivatives as peroxisome proliferator-activated receptor {gamma} agonists in colon cancer cells","volume":"6","author":"Chintharlapalli","year":"2007","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.bioorg.2025.108307_bb0140","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.cbi.2017.04.009","article-title":"Methotrexate hepatotoxicity is associated with oxidative stress, and down-regulation of PPAR\u03b3 and Nrf2: protective effect of 18\u03b2-Glycyrrhetinic acid","volume":"270","author":"Mahmoud","year":"2017","journal-title":"Chem. Biol. Interact."},{"issue":"12","key":"10.1016\/j.bioorg.2025.108307_bb0145","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.3390\/biom13121752","article-title":"Integrin \u03b16\u03b24 confers doxorubicin resistance in cancer cells by suppressing caspase-3-mediated apoptosis: involvement of N-glycans on \u03b24 integrin subunit","volume":"13","author":"Kariya","year":"2023","journal-title":"Biomolecules"},{"key":"10.1016\/j.bioorg.2025.108307_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.110284","article-title":"A narrative review of the role of exosomes and caveolin-1 in liver diseases and cancer","volume":"120","author":"Jiang","year":"2023","journal-title":"Int. Immunopharmacol."},{"issue":"7","key":"10.1016\/j.bioorg.2025.108307_bb0155","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/j.biocel.2012.04.005","article-title":"The zinc finger transcription factor ZKSCAN3 promotes prostate cancer cell migration","volume":"44","author":"Zhang","year":"2012","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.bioorg.2025.108307_bb0160","doi-asserted-by":"crossref","first-page":"101815","DOI":"10.1016\/j.jscs.2024.101815","article-title":"Structure\u2013Activity relationship (SAR) of 18\u03b2-glycyrrhetinic acid derivatives on their antitumor activity through the PPAR\u03b3 receptor and caspase-3 pathway","volume":"28","author":"Sun","year":"2024","journal-title":"J. Saudi Chem. Soc."},{"issue":"34","key":"10.1016\/j.bioorg.2025.108307_bb0165","doi-asserted-by":"crossref","first-page":"9643","DOI":"10.1021\/acs.jafc.9b03442","article-title":"Modification, antitumor activity, and targeted PPAR\u03b3 study of 18\u03b2-glycyrrhetinic acid, an important active ingredient of licorice","volume":"67","author":"Sun","year":"2019","journal-title":"J. Agric. Food Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108307_bb0170","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1080\/07391102.2019.1570868","article-title":"2D- and 3D-QSAR modelling, molecular docking and in vitro evaluation studies on 18\u03b2-glycyrrhetinic acid derivatives against triplenegative breast cancer cell line","volume":"38","author":"Shukla","year":"2020","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"10","key":"10.1016\/j.bioorg.2025.108307_bb0175","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/j.str.2007.07.014","article-title":"Partial agonists activate PPAR\u03b3 using a helix 12 independent mechanism","volume":"15","author":"Bruning","year":"2007","journal-title":"Structure"},{"key":"10.1016\/j.bioorg.2025.108307_bb0180","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.bioorg.2018.12.036","article-title":"Mitochondria-targeted triphenylphosphonium conjugated glycyrrhetinic acid derivatives as potent anticancer drugs","volume":"85","author":"Jin","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2025.108307_bb0185","doi-asserted-by":"crossref","first-page":"W5","DOI":"10.1093\/nar\/gkab255","article-title":"ADMETlab 2.0: an integrated online platform for accurate and comprehensive predictions of ADMET properties","volume":"49","author":"Xiong","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bioorg.2025.108307_bb0190","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.softx.2015.06.001","article-title":"GROMACS: high performance molecular simulations through multi-level parallelism from laptops to supercomputers","volume":"1-2","author":"Abraham","year":"2015","journal-title":"SoftwareX"},{"key":"10.1016\/j.bioorg.2025.108307_bb0195","doi-asserted-by":"crossref","first-page":"155494","DOI":"10.1016\/j.phymed.2024.155494","article-title":"Asiaticoside exerts neuroprotection through targeting NLRP3 inflammasome activation","volume":"127","author":"He","year":"2024","journal-title":"Phytomedicine"},{"key":"10.1016\/j.bioorg.2025.108307_bb0200","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.ejmech.2017.08.002","article-title":"Novel unsaturated glycyrrhetic acids derivatives: design, synthesis and anti-inflammatory activity","volume":"139","author":"Li","year":"2017","journal-title":"Eur. J. Med. Chem."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825001877?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825001877?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T21:34:37Z","timestamp":1763847277000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206825001877"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":40,"alternative-id":["S0045206825001877"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.108307","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis and antitumor activity evaluation of novel modified 18\u03b2-glycyrrhetinate derivatives as PPAR\u03b3 agonists","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.108307","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108307"}}